Treatment Induced Cytotoxic T-Cell Modulation in Multiple Myeloma Patients

The biology of plasma cell dyscrasias (PCD) involves both genetic and immune-related factors. Since genetic lesions are necessary but not sufficient for Multiple Myeloma (MM) evolution, several authors hypothesized that immune dysfunction involving both B and T cell counterparts plays a key role in...

全面介紹

書目詳細資料

Principais autores:	Gregorio Barilà, Laura Pavan, Susanna Vedovato, Tamara Berno, Mariella Lo Schirico, Massimiliano Arangio Febbo, Antonella Teramo, Giulia Calabretto, Cristina Vicenzetto, Vanessa Rebecca Gasparini, Anna Fregnani, Sabrina Manni, Valentina Trimarco, Samuela Carraro, Monica Facco, Francesco Piazza, Gianpietro Semenzato, Renato Zambello
格式:	Artigo
語言:	Inglês
出版:	Frontiers Media S.A. 2021-06-01
叢編:	Frontiers in Oncology
主題:	multiple myeloma immunophenotyping treatment lenalidomide ASCT-autologous stem cell transplantation cytotoxic response
在線閱讀:	https://www.frontiersin.org/articles/10.3389/fonc.2021.682658/full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!